We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$74.8B
AUM Growth
-$4.94B
Cap. Flow
-$13.1B
Cap. Flow %
-17.46%
Top 10 Hldgs %
25.98%
Holding
2,503
New
223
Increased
806
Reduced
858
Closed
183

Top Buys

Rank Stock Value
1
CBRE icon
CBRE Group
CBRE
+$247M
2
AMD icon
Advanced Micro Devices
AMD
+$236M
3
CX icon
Cemex
CX
+$212M
4
MDT icon
Medtronic
MDT
+$191M
5
MRVL icon
Marvell Technology
MRVL
+$177M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$540M
2
NVDA icon
NVIDIA
NVDA
+$460M
3
CB icon
Chubb
CB
+$448M
4
MSFT icon
Microsoft
MSFT
+$439M
5
AEP icon
American Electric Power
AEP
+$388M

Sector Composition

Rank Sector Weight
1 Technology 25.58%
2 Financials 14.16%
3 Healthcare 13.43%
4 Consumer Discretionary 9.58%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBRX icon
2176
ImmunityBio
IBRX
$7.68B
$0 ﹤0.01%
98
-172
-64% -$796
IEX icon
2177
IDEX
IEX
$17.5B
-132
Closed -$26K
IFF icon
2178
International Flavors & Fragrances
IFF
$22.5B
-8
Closed
IFS icon
2179
Intercorp Financial Services
IFS
$6.58B
-443
Closed -$9K
IMTX icon
2180
Immatics
IMTX
$1.34B
$0 ﹤0.01%
87
-1,457
-94% -$17.3K
INDV icon
2181
Indivior Pharmaceuticals
INDV
$4.57B
-5,505
Closed -$88K
IOT icon
2182
Samsara
IOT
$22.6B
-17,352
Closed -$584K
IOVA icon
2183
Iovance Biotherapeutics
IOVA
$1.94B
$0 ﹤0.01%
65
-161
-71% -$1.52K
IPW icon
2184
iPower
IPW
$690K
-2
Closed
IQ icon
2185
iQIYI
IQ
$1.24B
-455,303
Closed -$1.67M
IR icon
2186
Ingersoll Rand
IR
$34.9B
-6,604
Closed -$599K
IREN icon
2187
Iris Energy
IREN
$13.9B
$0 ﹤0.01%
100
JBL icon
2188
Jabil
JBL
$35.5B
-6,609
Closed -$718K
JKHY icon
2189
Jack Henry & Associates
JKHY
$11B
$0 ﹤0.01%
+4
New +$677
JOE icon
2190
St. Joe Company
JOE
$3.7B
-807
Closed -$44K
JSPR icon
2191
Jasper Therapeutics
JSPR
$22M
$0 ﹤0.01%
17
-31
-65% -$617
KE
2192
Kimball Electronics
KE
$644M
-8,531
Closed -$187K
KEQU icon
2193
Kewaunee Scientific
KEQU
$104M
$0 ﹤0.01%
+22
New +$1.03K
KTOS icon
2194
Kratos Defense & Security Solutions
KTOS
$10.4B
-3,946
Closed -$78K
KYMR icon
2195
Kymera Therapeutics
KYMR
$8.68B
-2,856
Closed -$84K
LCTX icon
2196
Lineage Cell Therapeutics
LCTX
$279M
$0 ﹤0.01%
148
-255
-63% -$236
LEGH icon
2197
Legacy Housing
LEGH
$654M
-1,295
Closed -$29K
LEGN icon
2198
Legend Biotech
LEGN
$3.69B
$0 ﹤0.01%
9
-16
-64% -$852
LEVI icon
2199
Levi Strauss
LEVI
$9.53B
-6,033
Closed -$116K
LLYVK icon
2200
Liberty Live Group Series C
LLYVK
$9.54B
$0 ﹤0.01%
10

Similar funds

Lazard Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Lazard Asset Management held 2,503 positions worth $74.8B, down 6.2% from $79.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $13.1B in Q3 2024, closing 183 positions and reducing 858 holdings. Its most notable exit was Brookfield, an estimated $37.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Mizuho Financial worth $63.7M.

  • Lazard Asset Management's largest Q3 2024 buy was Mizuho Financial: 15,229,057 shares worth $63.7M.
  • Lazard Asset Management added most to CBRE Group in Q3 2024, an estimated $247M increase.
  • Lazard Asset Management's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $540M.
  • Lazard Asset Management fully exited Brookfield in Q3 2024, selling an estimated $37.2M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $74.8B portfolio in Q3 2024.
  • Lazard Asset Management opened 223 new positions and closed 183 in Q3 2024.
  • Lazard Asset Management's portfolio value fell 6.2% quarter-over-quarter to $74.8B.

Based on Lazard Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.